Business Wire Press Release.“This study has shown the benefits of dual-HER2 inhibition with tucatinib and trastuzumab in patients with HER2-positive metastatic colorectal cancer, including many ...

The FDA has now approved Tukysa in combination with Herceptin for treating adult patients with RAS wild-type, HER2-positive unresectable or metastatic colorectal cancer whose disease progressed ...

Mysterious ancient microorganisms that are neither bacteria nor viruses seem to play a role in colorectal cancer. This supports the idea that such microbes, which were thought to be harmless ...

CHICAGO — Trastuzumab deruxtecan plus pertuzumab showed significant improvement in PFS compared with taxane chemotherapy plus trastuzumab and pertuzumab across patients with HER2-positive ...

A man from Guelph, Ont. is fundraising for colorectal cancer after he had a cancer scare last year. While his results came back negative, a B.C. oncologist said there is an alarming increase of ...

New statistics show colorectal cancer is on the rise among younger adults. No one's sure why. But the trend is clear, so the question now is: What should Canada do about it?

Colorectal cancer is the fourth most common form of cancer in Canada and the second deadliest, according to data recently published by the World Health Organization (WHO). At the time, Dr. Freddie ...